Corellia AI
Marina Bell, an Associate Scientist at Corellia AI, has previous experience as a Research Associate at Champions Oncology, Inc., and as a Student Intern at U.S. Food and Drug Administration. Marina graduated with a degree in Biochemistry from St. Mary's College of Maryland in 2019. During their internship, Marina conducted lab work in the Cellular and Tissue Therapy Branch, focusing on the study of Mesenchymal Stromal Cells from specific gene mice.
This person is not in any teams
Corellia AI
Armed with an ever-growing understanding of cancer biology, Corellia AI was launched out of Champions Oncology, Inc. in 2023, leveraging Champions’ deep cancer dataset, rich suite of research platforms, and state-of-the-art experimental capabilities established over the past 15 years. Corellia AI has built a unique research ecosystem and partnered with world-leading biopharma and technology companies to execute our vision of building transformative first-in-class therapeutics.